Work

RNF2 ablation reprograms the tumor-immune microenvironment and stimulates durable NK and CD4+ T-cell-dependent antitumor immunity

Year: 2021

Type: article

Source: Nature Cancer

DOI: 10.1038/s43018-021-00263-z

Authors: Zhuo Zhang, Lin Luo, Chuan Xing, Yu Chen, Peng Xu, Mao Li, Ling Zeng, Chao Li, Sadashib Ghosh, Deborah Della Manna, Tim Townes, William J. Britt, Narendra Wajapeyee, Barry P. Sleckman, Zechen Chong, Jianmei Wu Leavenworth, Eddy S. Yang

Institutions: University of Alabama at Birmingham, UAB Medicine, O'Neal Comprehensive Cancer Center, Nantong University

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: U.S. Department of Defense, U.S. Department of Health and Human Services, American Association for Cancer Research, National Institutes of Health, National Cancer Institute, National Institute of General Medical Sciences, National Institute of Allergy and Infectious Diseases

Awards: G2457495176, Contribution of the effector Treg-B-antibody nexus to the regulation of CNS autoimmunity, G2859268975, BOOSTING THE SYSTEMIC AND IN SITU CD4+ T-CELL RESPONSES TO MALIGNANT GLIOMA BY ONCOLYTIC HSV VIROTHERAPY, G4123678710, A NOVEL DRUGGABLE EPIGENETIC VULNERABILITY PATHWAY IN BREAST CANCER, G686466276, G9000189032, Advanced genome and transcriptome analysis using long-read sequencing technologies

OpenAlex ID: W3208555519

FWCI: 1.384

Cites: 82

Cited by: 31

Related to: 10